Introduction to 9 19 2017 Session 1 Discussion
Exploring 9 19 2017 Session 1 Discussion reveals several interesting facts. Panelists discuss, and field questions from the audience.
9 19 2017 Session 1 Discussion Comprehensive Overview
MARK MCCLELLAN , Workshop Series Co-Chair Director Duke-Margolis Center for Health Policy. ELEANOR PERFETTO Senior Vice President, Strategic Initiatives National Health Council. DANIEL FORD Director, Institute for Clinical and Translational Research Johns Hopkins School of Medicine.
Moderated Panel
Summary & Highlights for 9 19 2017 Session 1 Discussion
- Andy Bindman, University of California, San Francisco.
- JOANNE WALDSTREICHER Chief Medical Officer Johnson&Johnson.
- MICHAEL SHERMAN Senior VP and Chief Medical Officer Harvard Pilgrim Health Care.
- Panelists discuss, and field questions from the audience.
- MICHAEL HORBERG Executive Director, Research, Community Benefit, and Medicaid Strategy Executive Director, Mid-Atlantic ...
Stay tuned for more updates related to 9 19 2017 Session 1 Discussion.